Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BVF INC/IL | 11-14-2023 | 09-30-2023 | 69 | 3,708,416,589 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 1 | $1,239,823,188 | 21,751,284 | 0.03 | 5.51 | 0 | 0.00 | 09-30-2023 |
IONIS PHARMACEUTICALS INC | COM | 2 | $181,649,246 | 4,004,613 | 0.00 | 2.28 | 2,728,039 | 213.70 | 09-30-2023 |
AXSOME THERAPEUTICS INC | COM | 3 | $148,942,579 | 2,131,100 | 0.00 | 2,131,100 | +Inf | 09-30-2023 | |
IDEAYA BIOSCIENCES INC | COM | 4 | $142,548,533 | 5,283,489 | 0.00 | 1.86 | 2,488,630 | 89.04 | 09-30-2023 |